Arkadios Wealth Advisors Acquires 828 Shares of iShares Biotechnology ETF $IBB

Arkadios Wealth Advisors raised its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 13.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,917 shares of the financial services provider’s stock after purchasing an additional 828 shares during the quarter. Arkadios Wealth Advisors’ holdings in iShares Biotechnology ETF were worth $875,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in IBB. Ramirez Asset Management Inc. purchased a new stake in shares of iShares Biotechnology ETF during the 1st quarter valued at about $26,000. Berkshire Money Management Inc. bought a new stake in iShares Biotechnology ETF during the second quarter worth approximately $28,000. Financial Gravity Asset Management Inc. purchased a new stake in iShares Biotechnology ETF during the first quarter valued at approximately $30,000. Woodside Wealth Management LLC purchased a new stake in iShares Biotechnology ETF during the first quarter valued at approximately $31,000. Finally, Harbor Asset Planning Inc. bought a new stake in shares of iShares Biotechnology ETF in the 2nd quarter valued at approximately $31,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 1.3%

Shares of iShares Biotechnology ETF stock opened at $159.38 on Monday. The stock has a 50 day moving average price of $146.78 and a 200-day moving average price of $134.41. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $159.79.

iShares Biotechnology ETF Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were given a dividend of $0.0828 per share. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.